Dren Bio is a company that develops power protein-based technologies. Its aim is to deplete pathogenic cells and agents in numerous diseases. Dren’s lead programs are focused on hematologic neoplasms and solid cancers. It also works in other areas such as auto-immune disorders and diseases of protein aggregation.